Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-54.37	18.45	40.44
Graham Fair Price	-0.30	651.03	653.01
PEG	-8208.53	-12.72	-0.15
Price/Book	-8.31	0.55	0.60
Price/Cash Flow	9.67	17.61	-16.06
Prices/Earnings	-6.29	17.41	18.58
Price/Sales	-8.25	0.69	0.75
Price/FCF	9.67	17.61	-16.06
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	18.04	0.13	0.11
Operating Margin	45.47	0.04	0.03
ROA	-1.83	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-2.16
ROIC	< 0.005	0.01	123.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.02	32.79
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.13	0.47	-78.17
EPS QOQ	1.21	-0.01	-98.87
FCF QOQ	-0.40	1.84	362.51
Revenue QOQ	0.06	< 0.005	-87.88
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	58.63	53.23	-9.21
Days Sales Outstanding (DSO)	50.70	48.18	-4.97
Inventory Turnover	1.54	1.69	10.15
Debt/Capitalization	0.61	0.62	0.16
Quick Ratio	0.47	0.48	1.22
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1525.75	1537.81	0.79
Cash	360.01	415.49	15.41
Capex	-29.00	-31.08	-7.19
Free Cash Flow	-57.49	48.44	-15.74
Revenue	1230.25	1239.20	0.73
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.82	0.81	-0.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.32	13.06	-53.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating